✦ LIBER ✦

Cellular resistance to DNA topoisomerase II inhibitors

✍ Scribed by Jacquemin-Sablon, A.; Casabianca-Pignède, M.R.; Crémier, S.; Delaporte, C.; Khelifa, T.; Larsen, A.K.; René, B.; Saucier, J.M.

Book ID: 123502503
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 132 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)90690-H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor cell resistance to DNA topoisomera

Tumor cell resistance to DNA topoisomerase II inhibitors: new developments

✍ William T. Beck; Susan E. Morgan; Yin-Yuan Mo; Uppoor G. Bhat 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Topoisomerase I inhibitors: selectivity

Topoisomerase I inhibitors: selectivity and cellular resistance

✍ Yves Pommier; Philippe Pourquier; Yoshimasa Urasaki; Jiaxi Wu; Gary S. Laco 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Catalytic inhibitors of DNA topoisomeras

Catalytic inhibitors of DNA topoisomerase II

✍ Toshiwo Andoh; Ryoji Ishida 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Novel mechanisms of resistance to inhibi

Novel mechanisms of resistance to inhibitors of DNA topoisomerases

✍ William T. Beck; Tayeb Khélifa; Hiroki Kusumoto; Yin-Yuan Mo; Queen Rodgers; Jud 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 1001 KB

Leukemias related to treatment with DNA

✍ Felix, Carolyn A. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract The epipodophyllotoxins etoposide and teniposide and other DNA topoisomerase II inhibitors including anthracyclines and dactinomycin are highly efficacious anticancer drugs. All are associated with a distinct form of leukemia characterized by chromosomal translocations as a treatment co

DNA topoisomerase II inhibitors: new app

DNA topoisomerase II inhibitors: new approaches to antitumour therapy

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB